• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MRI sequences evolve to assess flesh and flow

Article

Radiologists use a number of MR imaging techniques to evaluate cardiac morphology and function: free-breathing and breath-hold methods, black blood imaging, standard contrast-enhanced MR angiography, and a fast version called time-resolved MRA.

Radiologists use a number of MR imaging techniques to evaluate cardiac morphology and function: free-breathing and breath-hold methods, black blood imaging, standard contrast-enhanced MR angiography, and a fast version called time-resolved MRA.

Breath-hold turbo spin-echo techniques with double inversion pulse-to greatly reduce signal from the blood pool-are the workhorses to evaluate morphology, according to Dr. Charles Higgins, vice chair of radiology at the University of California, San Francisco. These sequences are performed with multiple slices going through the great vessels and the heart. Contrast-enhanced 3D MRA also can be used to evaluate morphology. In the chest or heart applications, 3D MRA images are generally acquired in either a coronal or sagittal plane.

Techniques for evaluating function have evolved from cine gradient-free-breathing and breath-hold versions-to hybrid echo-planar imaging sequences that allow a more rapid acquisition in cine sequence to steady-state free precession techniques (FFE, TFE, TrueFISP), which balance the gradients in all three planes to produce homogeneous signal from the blood pool during the entire cine acquisition period. These sequences are used to assess left and right ventricular function, regional function, and valvular function.

Regional ventricular function is assessed by wall motion evaluation, but cardiac MR also reveals wall thickening, which is a better way to assess regional function and wall motion, Higgins said. Cardiac MR has surpassed transesophageal echocardiography for evaluating valvular function. By acquiring images as rapidly as 40 frames per cardiac cycle (within a 12-second breath-hold period), one can see mitral and aortic valve motion.

To measure blood flow, Higgins and colleagues use quantitative phase imaging, or velocity-encoded cine MR. They initially used this technique to quantify the amount of valvular regurgitation. Forward flow can be measured in systole and backward flow in diastole when images are acquired in about 16 frames per cardiac cycle, evenly spaced.

"This is one of the few techniques that can accurately measure the amount of valvular insufficiency," he said.

Referrals to assess patients with congenital heart disease are common, particularly to evaluate the severity of pulmonary insufficiency in patients who have had tetralogies of Fallot repair. The velocity-encoded cine MR technique measures blood flow in the direction of the pulmonary arch.

To assess tumors, Higgins suggests a wide field-of-view, a morphologic technique that is ECG-gated to every heartbeat, and the acquisition of axial images before and after gadolinium administration.

"We always do a cine MR sequence, which can tell us whether a mass within the heart is a blood clot or a tumor-perhaps one of the biggest differentials one has to make," he said.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.